Albuplatin

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAlbuplatin
Drug Alias Namealbumin-targeted maleimide-containing platinum (IV) prodrug (P4 Therpeutics/University of Vienna)
ClassificationSmall molecules
Mechanisms of ActionSerum albumin modulatorsApoptosis stimulants
TargetsSerum albumin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesP4 Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A